New toolkit launched to help repurposed medicines reach patients
The toolkit helps researchers, charities and others navigate the opportunities and challenges of repurposing medicines.
LifeArc’s Head of Ventures, Clare Terlouw speaks with @FT Global Pharma Correspondent @hannahkuchler discussing RQ… https://t.co/fqrxEXr3Xf
LifeArc scientist awarded prestigious industrial fellowship
LifeArc scientist Finbar Gaffey awarded a coveted industrial fellowship from the Royal Commission for the Exhibition of 1851.
Aisling Burnand CBE, 1964-2022
It is with deep sadness that we share the news that Aisling Burnand CBE passed away on Monday 19 September 2022.
Separate science from politics: save the UK’s science sector
LifeArc's Chief Scientific Officer calls for UK science to continue to be a contributor to the Horizon Europe programme.
Seven questions about LifeArc’s 2030 ambitions
Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.
Advancing novel gene therapies into the clinic
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
Study reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
Startup wins first Advise & Connect Innovation Award
iLOF is a startup that has a novel technology with the potential to transform personalised medicine.
Milner Therapeutics Institute and LifeArc extend strategic partnership
Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics